Compound · clinical trials

MDR-001 clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 4 trials in our China register that name MDR-001 as an intervention. Synced 10 Nov 2026

4Current trials

0Recruiting now

1Lead sponsor

1Country register

Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov registry records · Synced 10 Nov 2026 · Editorial standards

At a glance

MDR-001 is named as an intervention in 4 current clinical trials in our China register. None are recruiting at the moment. The most common phase is Phase 1. The lead sponsor is MindRank AI Ltd. The most-studied condition is Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B).

Patient leaflets for MDR-001

The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.

UK
United Kingdom: Search MHRA Products
Patient information leaflets and SmPCs for UK-licensed products.
US
United States: Search DailyMed
FDA-approved labels, including patient and medication guides.

Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.

Trials by status

Not yet open4100%

Trials by phase

Phase 1375%
Phase 3125%

Clinical trials of MDR-001

4 trials

Study	Phase	Status	Lead sponsor	Registers
A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE） NCT07274137 · ClinicalTrials.gov ↗ · Overweight or Obesity	Phase 3	Not yet open	MindRank AI Ltd	China
Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or Overweight NCT07110766 · ClinicalTrials.gov ↗ · Obesity &Amp; Overweight	Phase 1	Not yet open	MindRank AI Ltd	China
Drug-Drug Interaction Study of MDR-001 With Rifampin and Itraconazole in Healthy Adult Participants NCT07550621 · ClinicalTrials.gov ↗ · Healthy Volunteers (HV)	Phase 1	Not yet open	MindRank AI Ltd	China
Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment NCT07550634 · ClinicalTrials.gov ↗ · Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B), Hepatic Insufficiency (MeSH ID: D048550)	Phase 1	Not yet open	MindRank AI Ltd	China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

Conditions studied with MDR-001

5 conditions

Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B)1Hepatic Insufficiency (MeSH ID: D048550)1Overweight or Obesity1Healthy Volunteers (HV)1Obesity &Amp; Overweight1

By country register

Register	Trials	Recruiting
Clinical trials in China	4	0

A trial with sites in more than one country appears in each of those registers.

Related compounds

Questions about MDR-001 trials

How many clinical trials are testing MDR-001?

4 current trials in our China register name MDR-001 as a drug or biological intervention, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.

Are MDR-001 trials recruiting patients?

Not at the moment. None of the 4 trials in our registers is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.

Who sponsors MDR-001 clinical trials?

The lead sponsor is MindRank AI Ltd. The number in brackets is how many trials each organisation leads.

Where does this information come from?

Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how MDR-001 works or whether it is effective, and it is not medical advice.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how MDR-001 works or whether it is effective. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists MDR-001 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.